In BRCA tumors, the level of FOXA1 is lower in stage N0; whereas in KIRP tumors, the expression level of FOXA1 is significantly upregulated in a sequential manner from stage N0 to N1 to N2 (Supplementary Fig. 7D). Here, FOXA1 is linked to invasive breast carcinoma.